Table 1.

Summary of experimental conditions used in Figures 2-6.

	Age @ Injury (days)	Genotype(s)	Adex-cre (PFU)	CTX (µg)	Injection Volume (µl)
Figure 2	10-13	caALK2fl/fl;mTmG+/-or caALK2fl/fl	0.7x109	0.3	10
Figure 3 A-C	9	caALK2fl/-	1.0x109 or 1.9x109	0.3	10 or 40
Figure 3 D-F	9	caALK2fl/- or caALK2fl/fl	1.9x109	0.3 @ P7-9 or only P9	10
Figure 4	7	caALK2fl/-	1.0x109	none	10
Figure 5	21	caALK2fl/fl	5.0x109	3.0	20
Figure 6	28	caALK2fl/fl	4.44x109	1.5	20